Approval · Notice of Compliance 2928 · 1998
PLENDIL: Notice of Compliance 2928
Issued February 5, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2928
- Date
- February 5, 1998
- Company
- Astra Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph
- Therapeutic class
- Antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLENDIL | Not yet assigned | — |
Medicinal ingredients
- FELODIPINE 2.5 MG per TAB
- FELODIPINE 5 MG per TAB
- FELODIPINE 10 MG per TAB